Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species Previous and current positions include

Previous and current positions include

He currently is holding a position as clinical investigation manager at Vitrolife

From 1991 to 2013 he was Director of the Centre de recherche en reproduction

Clinical Epigenetics 11(1): 21

across the CARE Fertility Group in the UK and Ireland

Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species Previous and current positions includeFrequent Loss of Heterozygosity in CRISPR Cas9 edited Early Human Embryos DR. GREGORIO ALANIS LOBATO Gregorio obtained a BEng degree in Computer Systems Engineering at the National Polytechnic Institute in Mexico before moving to KAUST in Saudia Arabia to pursue MSc and PhD degrees in Computer Science and Computational Biology, respectively. Then, he became a postdoctoral fellow at the IMB in Mainz, Germany, where he developed methods to study the